Article Text

Download PDFPDF

P037 Multiple roles of phospholipase C-ETA2, as a novel C2 domain containing protein, in the pathogenesis of rheumatoid arthritis
  1. SI Lee1,
  2. JH Park1,
  3. HS Noh1,
  4. W-U Kim2
  1. 1Internal Medicine, Gyeongsang National University School of Medicine, Jinju
  2. 2Internal Medicine, the Catholic University of Korea, Seoul, Korea, Republic of Ireland


Introduction The C2 domain is a Ca2+-dependent membrane-targeting motif found in many cellular proteins involved in signal transduction or inflammation pathway. However, the effects of C2 domain-containing proteins in the fibroblast-like synoviocyte (FLS) of rheumatoid arthritis (RA) have not yet been elucidated.

Objectives The aim of this study was to screen novel C2 domain-containing proteins related to aggressiveness of FLS, and confirm the precise roles of target protein in RA.

Methods We transduced RA-FLS with a recombinant adenovirus expressing a C2 domain library. To confirm the effect of phospholipase C-eta2 (PLCH2), as a candidate C2 domain-containing target protein, we established stable MH7A cell lines overexpressing GFP-tagged PLCH2. We also conducted in vitro and in vivo experiments using a recombinant adenovirus expressing the full length form of PLCH2 or C2 domain of PLCH2 (C2-PLCH2).

Results Several C2 domain-containing proteins were identified whose over-expression resulted in reduced proliferation and NF-kB activity of RA-FLS. Among those, we focused on PLCH2 in this study. PLCH2 levels were significantly decreased in RA-FLS and synovium than OA. PLCH2 and C2-PLCH2 suppressed cell invasion and migration, cytokines production, and matrix metalloproteinase secretion in RA-FLS and stable MH7A cell lines compared to control. PLCH2 and C2-PLCH2 sensitised RA-FLS to apoptosis in vitro and in vivo model of matrigel implants engrafted into immunodeficient mice. PLCH2 and C2-PLCH2 further decreased arthritis severity in collagen-induced arthritis (CIA) mouse model.

Conclusions Our results showed that invasive characteristics of RA-FLS and inflammatory arthritis of CIA are reduced by PLCH2 and C2 domain of PLCH2. Therefore C2 domain of PLCH2 may have therapeutic potential for RA.


  1. . Farah CA, Sossin WS. The role of C2 domains in PKC signalling. Adv Exp Med Biol2012;740:663–83.

  2. . Yáñez M, Gil-Longo J, Campos-Toimil M. Calcium binding proteins. Adv Exp Med Biol2012;740:461–82.

  3. . Friedrich R, Yeheskel A, Ashery U. DOC2B, C2 domains, and calcium: A tale of intricate interactions. Mol Neurobiol2010February;41(1):42–51.

  4. . Zhou Y, Sondek J, Harden TK. Activation of human phospholipase C-eta2 by Gbetagamma. Biochemistry2008April 15;47(15):4410–7.

  5. . Popovics P, Beswick W, Guild SB, Cramb G, Morgan K, Millar RP, Stewart AJ. Phospholipase C-η2 is activated by elevated intracellular Ca(2+) levels. Cell Signal2011November;23(11):1777–84.

Acknowledgements This work was supported by grants (NRF-2014R1A2A1A11051360 and NRF-2015R1A5A2008833) from the National Research Foundation of Korea (NRF) funded by the Korean government (MSIP).

Disclosure of interest None declared

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.